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Abstract.  We have obtained expression of a cDNA 
clone for human cathepsin D  in Xenopus laevis oo- 
cytes. Biosynthetic studies with [3sS]methionine  la- 
beling demonstrated that most of the cathepsin D 
remained intracellular and underwent proteolytic cleav- 
age, converting a precursor of M, 47,000  D to a ma- 
ture form of Mr 39,000  D  with processing intermedi- 
ates of Mr 43,000-41,000  D. >90%  of the cathepsin D 
synthesized by ooc3:tes bound to a mannose 6-phos- 
phate (Man-6-P) receptor affinity column, indicating 
the presence of phosphomannosyl residues. An analy- 
sis of [2-3H]mannose-labeled oligosaccharides directly 
demonstrated phosphomannosyl residues on cathepsin 
D.  Sucrose-gradient fractionation, performed to define 
the membranous compartments that cathepsin D  tra- 
versed during its biosynthesis, demonstrated that ca- 
thepsin D  is targeted to a subpopulation of yolk plate- 
lets, the oocyte equivalent of a lysosome. Xenopus 
oocytes were able to endocytose lysosomal enzymes 
from the medium and this uptake was inhibited by 
Man-6-P, thus demonstrating the presence of Man-6-P 
receptors in these cells. Therefore, the entire Man-6-P 
dependent pathway for targeting of lysosomal enzymes 
is present in the oocytes. Xenopus oocytes should be a 
useful system for examining signals responsible for the 
specific targeting of lysosomal enzymes to lysosomes. 
C 
ATHEPSIN D is a lysosomal aspartyl protease that is 
present in all mammalian cells (1). The biosynthesis 
and intracellular targeting of cathepsin D have been 
well studied (6,  12,  15,  16,  30) and have helped to define 
the posttranslational  modifications that are characteristic  of 
many lysosomal enzymes. Biosynthetic studies have demon- 
strated that cathepsin D is synthesized in the rough endoplas- 
mic reticulum as a preproprotein (6, 30), with the signal pep- 
tide removed in this organelle. Procathepsin D, with reported 
Mr of 46,000-53,000 D (17), is then translocated to the Golgi 
apparatus  where  its  high  mannose-type oligosaccharides 
may acquire phosphomannosyl  residues  (15). These man- 
nose 6-phosphate  (Man-6-P) I residues are recognized  by 
specific receptors (Man-6-P receptor) in the Golgi complex, 
resulting  in sorting of lysosomal  enzymes from secretory 
proteins and subsequent targeting of lysosomal enzymes to 
lysosomes (3). Some of  the procathepsin D molecules escape 
this segregation and are secreted. The majority of  the cathep- 
sin D, however, is targeted to lysosomes and undergoes fur- 
ther proteolytic  cleavages. The first cleavage is initiated in 
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prelysosomal compartments (12) and involves removal of the 
44 amino acid propiece (6) to generate an intermediate  of 
reported Mr 44,000-47,000  D (17). A second cleavage, oc- 
curring in  lysosomal  compartments,  processes  the  inter- 
mediate to a two-chain form with noncovalently associated 
subunits of Mr 31,000 and 14,000 D (17). Very late in the 
biosynthesis, the Mr 31,000-D chain undergoes a further Mr 
"01,000-D decrease in mass,  which most likely represents 
proteolytic trimming at both its carboxyl and amino termini 
(5, 8). 
The acquisition  of Man-6-P residues  by lysosomal  en- 
zymes is the determining step for the pathway that results in 
the segregation  of these hydrolases  into  lysosomes.  This 
Man-6-P recognition marker is generated by the sequential 
action of two enzymes (13). First, N-acetylglucosamine-1- 
phosphate  is transferred to selected mannose residues on 
lysosomal enzymes, giving rise to a phosphodiester  inter- 
mediate.  The N-acetylglucosamine  is  then removed  by a 
second enzyme to expose the Man-6-P monoester signal. 
The first reaction is catalyzed by UDP-GlcNAc:lysosomal 
enzyme  N-acetylglucosaminylphosphotransferase  (phospho- 
transferase) (19, 28). This enzyme is able to selectively phos- 
phorylate lysosomal enzymes over nonlysosomal glycopro- 
teins containing similar oligosaccharides by recognition of a 
protein domain that is common to many lysosomal enzymes 
(25, 27). However, the identity of this common protein do- 
main is unknown. 
￿9  The Rockefeller University Press, 0021-9525/87/11/1937/9  $2.00 
The Journal of Celt Biology, Volume 105, November 1987 1937-1945  1937 As a first step towards understanding  the lysosomal protein 
recognition  domain,  we have previously isolated  a cDNA 
clone containing  the complete protein-encoding  region for 
human cathepsin D (8). We next sought to express the cDNA 
in an appropriate system which could be conveniently  used 
to test mutations generated  in specific regions of the coding 
sequence.  We report here the expression of the human ca- 
thepsin D cDNA in Xenopus laevis  oocytes and demonstrate 
that the cathepsin D acquires phosphomannosyl  residues and 
is targeted to lysosomes. 
Materials and Methods 
Antiserum 
Human placental cathepsin D was purified to homogeneity by previously de- 
scribed methods (33) and injected  with adjuvants  into rabbits.  After two 
booster injections, serum was collected and titered by immunoprecipitation 
of iodinated  cathepsin D. 
Plasmids/Oocyte  Expression 
A cDNA clone for human catbepsin D has been previously described (8). 
G/C homopolymer tails were removed from 5' and 3' ends of the clone by 
Bal 31 digestion (New England Biolabs, Beverly, MA) followed by DNA 
sequencing (32) to determine the extent of digestion.  The cDNA was then 
cloned into the expression vector pSP64 (Promega Biotec, Madison, WI). 
RNA transcripts were synthesized in vitro from cloned cDNAs with SP6 
polymerase (New England Biolabs) as described by Melton et al. (26) ex- 
cept that Grrp was reduced to 0.1 mM and RNAs were capped by transcrip- 
tion in the presence of 0.5 mM G(5')ppp(3')G (Pharmacia Fine Chemicals, 
Piscntaway, NJ). The amount of transcript produced was monitored by in- 
corporation of [r  After transcription, RNAs were precipitated 
with ethanol and resuspended in diethylpyrocarbonate-trented  water. 
Stage V-VI nocytes  were obtained from large  Xenopus  lae~is females 
(Nasco,  Fort Atkinson, WI) and maintained in modified  Barth's  saline 
(MBS) at 19~  as described (2). Ooeytes were injected with 50 nl of RNA 
(150-200 ng/IXl)  and then stored overnight  in MBS to allow removal of dam- 
aged oocytes prior to labeling. For labeling with [35S]methionine (>1,000 
Ci/mmol, Amersham Corp., Arlington Heights,  IL), oocytes  were incu- 
bated in groups of 10-20 with 10 I.tl/nocyte of MBS containing 5 % fetal 
bovine serum and 1 mCi/ml l~SS]methionine.  FOr labeling with [2-3H]man  - 
nose (14 Ci/mmol, ICN, St. Louis, MO), 200 injected oocytes were incu- 
bated for 48 h in 0.5 ml of MBS containing 5 mCi/ml [2-3H]mannose.  At 
the termination of incubations, ooeyms and media were separately  col- 
lected,  rapidly  frozen on dry ice, and stored at -20~ 
Immune Precipitations 
Frozen, labeled oocytes were homogenized in 40 ~tl/oocyte of 50 mM imida- 
zole, pH 7, 150 mM NaCl, 5 mM Na I~-glycerophosphate, 1% Triton X-100, 
0.2  TIU/ml  aprotinin (Sigma  Chemical Co.,  St.  Louis,  MO),  1  mM 
phenylmethylsulphonyl  fluoride  (PMSF)  and  1:I000  antiprotease  mix 
(buffer I), and centrifuged in a eppendorf microfuge for 2 rain at 4~  to re- 
move insolubles.  The antiprotease mix consisted of antipain, chymostatin, 
leupeptln, and pepstatin (each at 2 mg/ml) and aprotinin (If)  TIU/ml) in 50% 
DMSO. 
Equivalent samples (corresponding to two oocytes)  of cell extract and 
medium samples were diluted into 0.5 ml of immunoprecipitation buffer 
(0.1 M KCI, 5 mM MgCI2, 1% Triton X-100, 0.5% SDS,  1% sodium deox- 
ycholate,  1 mM PMSF,  0.1 M Tris-HCl, pH 8) and incubated with an- 
ticathepsin D serum or nonimmune serum for 4-18 h at 4~  Protein A- 
Sepharose (Sigma Chemical Co.) was then added and allowed to incubate 
for 1-2 h at 4~  The resin was sedimented  and washed four times with 1 
ml of 1% Triton X-100, 0.1 M Tris-HC1, pH 8, 1(30  mM NaCI, 0.2 TIU/rrd 
aprotinin, 1 mM PMSF followed by two washes with 0.1 M Tris-HCl, pH 
8. Immunoprecipitated  proteins were dissociated  from the resin by heating 
for 5 min at 100"C in SDS gel sample buffer, electrophoresed through a 
SDS/polyacrylamide  gel (SDS-PAGE) (23) under non.reducing conditions, 
and flnorographed  using ENhance (New England Nnclear,  Boston, MA). 
When indicated,  the appropriate regions of the dried gel were excised and 
solubilized with 90% NCS tissue solubilizer (Amersham Corp.), and radio- 
activity was  measured by  liquid scintillation counting according  to the 
manufacturer's instructions. 
Man-6-P  Receptor  A2~inity Chromatography 
Bovine liver 215-kD Man-6-P receptor was purified  and linked to Afligel 
15 as previously described (36). Columns were equilibrated in buffer con- 
raining 50 mM imidazole,  pH 6.5,  150 mM NaC1, 5 mM Na 13-glycero- 
phosphate, 0.05 % Triton X-100, and 1:1000  antiprotease mix (buffer II). All 
manipulations were performed at 4"C. 
Cell extract and medium samples were diluted into 0.4 ml of buffer II 
and applied to a 1.75-ml Man-6-P receptor column. The column was washed 
with buffer II until no further radioactivity  was detected in the buffer run 
through. The column was  then eluted  sequentially  with 2  mM glucose 
6-phosphate (GIc-6-P) in buffer H followed by 5 mM Man-6-P in buffer II. 
Fractions corresponding to the column run-through and Man-6-P-eluted 
material were separately pooled, adjusted to contain 50 mM Tris-HCI,  pH 
8, and I% Triton X-100, and then immunoprecipimted  as described above. 
The Glc-6-P-eluted fractions were free of radioactivity  and were not ana- 
lyzed further. 
Oligosaccharide  Analysis 
[35S]methionine-labeled cathepsin D immunoprecipitates  were treated with 
1 mU of endo-l[~-N-acetylglucosaminidase H (endo H; Boerhinger Mann- 
heim, Indianapolis, IN) by dilution of SDS-disaggregated  immunoprecipi- 
tates with 50 mM citrate-phosphate,  pH 5.6, to a final SDS concentration 
of 0.25 %. After overnight incubation under a toluene atmosphere at 37"C, 
proteins were precipitated  with trichloroacetic acid, washed with acetone, 
and dissolved  in SDS sample buffer. 
Oocytes that were injected with cathepsin D RNA and then labeled with 
[2-3H]mannose were homogenized  in buffer  I and applied to a  Man-6-P 
receptor column. Cathepsin D was isolated from the Man-6-P eluate by im- 
munoprecipitation.  Glycopeptides  were prepared by pronase digestion of 
the SDS-disaggregated  immunoprecipitate and applied to concanavalin A 
(Con A)-Sepharose columns as previously described (4). The glycopeptides 
that eluted with 100 mM r  were desalted by chromatogra- 
phy on Sephadex G-25 and then digested with 2 mU of endo H in 0.1 ml 
of 50 mM citrate-phosphate,  pH 5.6. A sample of the endo H digest was 
diluted with 2 mM Tris, pH 8, and analyzed by QAE-Sephadex chromatog- 
raphy (35). Separate samples were subjected to mild acid hydrolysis (sample 
diluted into 0.5 rrd of 0.01 N HCI and heated 30 min at 100~  and/or diges- 
tion with Escherichia  coli alkaline phosphatase (a generous gift of Dr. M. 
Schlesinger,  Washington  University,  St.  Louis,  MO)  as previously de- 
scribed (35) followed by QAE-Sephadex  analysis. 
Sucrose-Gradient Fractionation 
Oocytes  were injected with cathepsin D  RNA and then incubated with 
[35S]methionine for 5, 30, or 70 h. Some labeled oocytes were removed af- 
ter 24 and 64 h and were incubated with 0.5 mg/ml vitellogenin  (VG) in 
MBS for 6 h. For each gradient, 25 oocytes (15-25 labeled oocytes,  sup- 
plemented with unlabeled  oocytes where necessary) were then homogenized 
in 1 ml of cold homogenization  buffer (0.25 M sucrose,  0.5 mM MgCI2, 
1 mM EGTA, 5 mM Hepes,  pH 7.4) using six to seven slow strokes  with 
the loose-fitting pestle of a Dounee homogenizer (Kontes Co., Evanston, 
IL).  The homogenates  were filtered through Nitex  nylon screen (52-t.tm 
mesh size: Tetko, Inc., Depew, NY) and then applied to the top of linear 
sucrose gradients as previously described (37). Cathepsin D was immuno- 
precipitated from gradient fractions by fourfold dilution into immunoprecip- 
itation buffer. ~-Hexosaminidase (NAG) was assayed colorimetrically  as de- 
scribed by Hall et al. (14) except that all incubation mixtures contained 0.1% 
Triton X-100. 
Lysosomal  Enzyme Uptake 
Oocytes were isolated by manual dissection or were freed of follicle cells 
and other ovarian tissues by collagenase  dissociation (2).  Phosphorylated 
lysosomal enzymes were isolated from BW5147 PHAR1.8 cell (34) NH4Cl- 
induced secretions and iodinated (a generous girl of  J. Duncan of this labora- 
tory). Groups of 15-30 oocytes were incubated in 0.3 ml of MBS containing 
5% fetal bovine serum and 30,000 cpm 1251-lysosomal  enzymes for 6-24 h 
at 20~  in the presence and absence of 10 mM Man-6-P or 10 mM GIe-6-P. 
Oocytes were then washed extensively with MBS and counted directly for 
~25I in a gamma-counter (Beckman  Instruments, Inc., Palo Alto,  CA). 
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Oocytes were microinjected with cathepsin D RNA and then la- 
beled  with  [35S]methionine for the  indicated times.  Equivalent 
samples of an oocyte detergent extract (C) and the medium (M) 
were then  immunoprecipitated  with  anticathepsin  D  antiserum 
(lanes 1-10) or nonimmune serum (lane//) and analyzed by SDS- 
PAGE (10% gel) and fluorography. The band at Mr 59,000 D is 
nonspecific as it appears in the nonimmune serum control (lane//; 
same band present in cell and medium samples). Molecular size 
standards are in kilodaltons. 
Figure 2.  Binding of [35Slmethionine-labeled  cathepsin D to the 
Man-6-P receptor. Oocyte detergent homogenates (Fig. 1) from the 
indicated times were applied to a Man-6-P receptor column and 
specifically eluted with 5 mM mannose 6-P. Fractions correspond- 
ing to the column run-through (RT) and mannose 6-P eluate (M6P) 
were immunoprecipitated with anticathepsin D antiserum and ana- 
lyzed by SDS-PAGE and fluorography. 
Results 
Expression of  Cathepsin D in Xenopus Oocytes 
Oocytes were microinjected with a cathepsin D RNA mes- 
sage generated by in vitro transcription of the cloned cDNA 
inserted behind the bacteriophage SP6 promoter.  Injected 
oocytes were incubated with [35S]methionine  over a period 
of 75 h and cathepsin D associated with the oocytes and in 
the medium was immunoprecipitated with anticathepsin D 
antiserum (note that incubation past 20 h constitutes a chase 
in this system [2]). After 5 h of incubation, an M~ 47,000-D 
protein was  immunoprecipitated from the oocyte homoge- 
nate and first detected in the medium at 20 h (Fig.  1, lanes 
1 and 6, respectively). By 75 h of incubation,  ~5%  of the 
cathepsin D  molecules synthesized by the oocyte were se- 
creted (Fig.  1,  lane 10). The majority of the cathepsin D, 
however, remained cell-associated and was slowly processed 
to an Mr 39,000-D protein with apparent processing inter- 
mediates at Mr 43,000-41,000  D  (Fig.  1). 2 The disappear- 
ance of the Mr 47,000-D protein and sequential appearance 
of the M~ 43,000-41,000-D processing intermediates leading 
to  the  Mr  39,000-D  mature  protein  indicates  a  precur- 
sor-product  relationship  for  these  forms.  The  processed 
2. The electrophoretic mobilities differed when samples were prepared un- 
der reducing conditions. The Mr 47,000-D form did not change mobility. 
The processing intermediates were not resolved from each other and ran as 
one band with Mr 46,000 D. The MT 39,000-D form electrophoresed with 
apparent M~ 45,000 D. 
forms were not detected in the medium, consistent with the 
intraceilular location of cathepsin D processing as defined in 
mammalian cells (17). These immunoprecipitable proteins 
were not present in anticathepsin D antiserum precipitates of 
noninjected oocytes (data not shown) or in nonimmune an- 
tiserum precipitates of cathepsin D-injected oocytes (Fig.  1, 
lane H ). 
Proteins of M~ 31,000 and 14,000 D, corresponding to the 
heavy and light chains of cathepsin  D,  respectively, were 
only detected when  the  gels  were overexposed (data  not 
shown;  Mr  14,000  D  detected on higher-percentage gels). 
The amount of these forms detected was low (not >1% of all 
cathepsin D molecules) and highly variable and may actually 
represent minor proteolysis at a sensitive site during homog- 
enization rather than a true processing product of the cell. 
Phosphorylation of  Cathepsin D 
In mammalian cells, newly synthesized cathepsin D acquires 
phosphomannosyl residues (15),  which are required for its 
targeting to lysosomes by the Man-6-P receptor. To deter- 
mine whether cathepsin D  synthesized by oocytes also ac- 
quires  Man-6-P  residues,  [35S]methionine-labeled  oocyte 
homogenate and  media samples  were applied to Man-6-P 
receptor columns. The column was washed with buffer until 
no more radioactivity eluted,  then with 2  mM Glc-6-P, a 
sugar phosphate that does not interact with the receptor, and 
finally  with  5  mM  Man-6-P,  a  competitive inhibitor  for 
receptor binding.  The material in the column run-through 
and the Man-6-P eluate was then immunoprecipitated with 
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Percent 
Time  Sample  Run-through  Man-6-P eluate  phosphorylated 
h  cpm cathepsin  D  % 
5  Cells  2,248  416  16 
10  Cells  2,287  1,156  34 
20  Cells  3,490  12,510  78 
40  Cells  2,068  25,480  93 
75  Cells  547  23,765  98 
75*  Medium  453  790  64 
Appropriate regions of the dried gel shown in Fig. 2 were excised 
dioactivity  present was measured  by liquid scintillation  counting. 
* Determined from a separate experiment, not shown in Fig. 2. 
and the ra- 
anticathepsin D antiserum. As shown in Fig. 2, cathepsin D 
bound to the receptor column and was specifically eluted 
with  Man-6-P,  indicating  the  presence  of  the  Man-6-P 
marker. The extent of receptor binding of the intracellular 
cathepsin D increased from 16 to 98%  between 5 and 75 h 
of incubation with  [35S]methionine  (Fig.  2  and Table  I). 
64% of the secreted cathepsin D also bound to the receptor 
column (Table I). Although the level of  cathepsin D secretion 
varied between 5 and 25 % of  the total cathepsin D molecules 
synthesized by  oocytes  from  different animals  (data  not 
shown), these results demonstrate that the phosphorylation 
of cathepsin D by oocytes is very efficient, with a total level 
of phosphorylation (cells and medium material) of 93-97 %. 
In addition, the fractions which bound to the Man-6-P recep- 
tor column initially contained the precursor form (Fig.  2, 
lane 2)  and then,  with increasing time of incubation,  the 
processed forms of cathepsin D were detected; in contrast, 
the column run-through contained only the precursor form 
(Fig.  2).  This indicates that processing occurs after phos- 
phorylation. This is consistent with the sequence of events 
characterized for cathepsin D  in mammalian cells where 
phosphorylation occurs  in the early Golgi apparatus  fol- 
lowed by proteolytic cleavages subsequent  to targeting to 
prelysosomal and lysosomal organelles (12, 13,  17). 
Endogenous proteins in Xenopus oocytes are also capable 
of binding to a  Man-6-P  receptor column.  The extent of 
receptor binding for these proteins increased over the 75-h 
incubation period at a rate identical to that seen for cathepsin 
D  with  a  maximum  of  'ol.0%  of total  [35S]methionine- 
labeled endogenous proteins binding to the receptor column 
(data not shown). Lysosomal enzyme activities for three en- 
dogenous lysosomal enzymes were assayed in the receptor 
column run-through and Man-6-P eluate. The percentage of 
Table IL Lysosomal  Enzyme Binding to Phosphomannosyl 
Receptor Column in Xenopus Oocytes 
Enzyme  Run-through  Man-6-P eluate  Percent bound 
nmol product/h  % 
[$-Hexosaminidase  1,455  455  24 
[3-Galactosidase  16  13  45 
[3-Glucuronidase  1.9  0.8  30 
Cell extracts were applied to a Man-6-P receptor column. Run-through  and 
Man-6-P eluates were assayed for lysosomal  enzymes using 4-methyl-umbel- 
liferone substrates  as described (29). 
activity that bound to the column ranged from 24 to 45 % (Ta- 
ble II). Thus, lysosomal enzyme activity is associated with 
the endogenous proteins that bind to the Man-6-P receptor 
column. In addition, it is apparent that Xenopus oocytes do 
not rapidly degrade the Man-6-P marker,  as observed  in 
some mammalian cells (10), in that almost all of the newly 
synthesized,  intracellular  cathepsin  D  still  bound  to  the 
receptor column at the end point (75 h) of the experiment 
(Table I). The lower level of receptor binding observed for 
the endogenous lysosomal enzyme activities (Table II) prob- 
ably reflects dephosphorylation after extended residence in 
a lysosomal compartment. The presence of a small amount 
of  processed cathepsin D which does not bind to the receptor 
column, detected only after 75 h of incubation (Fig. 2, lane 
9), may also reflect this dephosphorylation. 
Oligosaccharide Analysis 
Cathepsin  D  immunoprecipitates of the  receptor  column 
run-through and Man-6-P eluates from the 20-h time point 
(Fig. 2, lanes 5 and 6, respectively) were treated with endo 
H. Both fractions showed increased mobility on SDS-PAGE 
after endo H treatment (Fig. 3), indicating that the oligosac- 
charide chains are of the high-mannose type. The observed 
Mr 4,000-D  decrease for all protein  species is consistent 
with  removal  of two  high-mannose-type oligosaccharide 
chains, indicating that both asparagine-linked glycosylation sig- 
nals on cathepsin D  (8) are being utilized. In addition, all 
of the processed forms of cathepsin D shifted independently 
(Fig.  3,  lanes 3  and 4),  indicating that the different elec- 
trophoretic mobilities are not due to oligosaccharide pro- 
cessing and most likely represent proteolytic cleavage. 
Further analysis of the oligosaccharides of cathepsin D 
was undertaken to directly demonstrate the presence of  phos- 
phomannosyl residues. As Xenopus oocytes inefficiently incor- 
porate mannose into oligosaccharides (P. Faust, unpublished 
observations), a large number of oocytes were microinjected 
with cathepsin D  RNA and labeled continuously with [2- 
Figure 3. Sensitivity  of cathep- 
sin D to endo-13-N-acetylglu- 
cosaminidase H. Cathepsin D 
was isolated by immunopre- 
cipitation from the  Man-6-P 
receptor column run-through 
(RT)  and  Man-6-P eluates 
(M6P) at the 20-h time point 
(Fig. 2, lanes 5 and 6). Immu- 
noprecipitates were then  in- 
cubated with or without endo- 
13  -N-acetylglucosaminidase  H 
(endo H)  followed by SDS- 
PAGE and fluorography. 
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Figure 4. Con A-Sepharose chromatography of cathepsin D glyco- 
peptides. Oocytes were injected with cathepsin D RNA and then la- 
beled  with  [2-3H]mannose for 48 h.  The oocytes were homog- 
enized and applied to a Man-6-P receptor column. Cathepsin D was 
then isolated from the Man-6-P eluate by immunoprecipitation. 
Glycopeptides generated by pronase digestion of the SDS-disaggre- 
gated immunoprecipitate were applied to a Con A-Sepharose col- 
umn. The column was eluted with 10 mM a-methylglucoside (MG) 
followed by 100 mM a-methylmannoside (MM). 
3H]mannose for 48 h.  The cellular homogenate was then 
applied to the Man-6-P receptor column and cathepsin D iso- 
lated  by  immunoprecipitation  from  the  Man-6-P  eluate. 
Similar immunoprecipitates so obtained from [35S]methio- 
nine-labeled samples  were found to be at least 90%  pure 
cathepsin D with respect to radioactivity by SDS-PAGE (see, 
for example, Fig. 2). After immunoprecipitation, the cathep- 
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Figure 5. QAE-Sephadex analysis of 
cathepsin  D  oligosaccharides.  The 
ct-methylmannoside-eluted  glyco- 
peptides  (Fig. 4)  were desalted on 
Sephadex-G25  and  digested  with 
endo H to release the oligosaccha- 
rides. Samples of the endo H reac- 
tion were applied to analytical QAE- 
Sephadex columns after (,4) no treat- 
ment,  (B) mild  acid treatment,  or 
(C) mild acid  +  alkaline phospha- 
tase treatment. 20, 70, 100, and 140 
refer to millimolar concentration of 
NaC1 in elution buffer. 
sin D was digested with pronase to generate glycopeptides, 
which were then applied to a column of Con A-Sepharose 
and eluted sequentially with 10 mM a-methylglucoside and 
100 mM a-methylmannoside. Under these conditions, com- 
plex-type  asparagine-linked  oligosaccharides  either  pass 
through the column or are eluted with ct-methylglucoside, 
whereas high-mannose-type oligosaccharides  require a-meth- 
ylmannoside for elution (4). 90% of the radioactivity bound 
to the column and required a-methylmannoside for elution 
(Fig. 4), consistent with the endo H analysis (Fig. 3) which 
demonstrated  high-mannose-type oligosaccharides  on  ca- 
thepsin D. 
The high-mannose glycopeptides were treated with endo 
H to release the oligosaccharides which were then analyzed 
for  the  presence of phosphomannosyl residues  by  QAE- 
Sephadex chromatography (35). Under the conditions used, 
neutral oligosaccharides pass through the resin while oligo- 
saccharides with one, two, three, or four net negative charges 
bind and are eluted with 20,  70,  100, and  140 mM NaCI, 
respectively. As shown in Fig. 5 A, 96 % of the radioactivity 
interacted with the resin and eluted at positions characteristic 
for oligosaccharides with one phosphodiester (20 mM NaCI), 
one phosphomonoester (70 mM NaCI),  and two phospho- 
monoesters (140 mM  NaC1).  Mild acid hydrolysis, which 
will remove the N-acetylglucosamine from phosphodiester 
residues, caused the 20 mM peak of radioactivity to disap- 
pear and shift to the 70 mM position (Fig. 5 B; the shift to 
70 mM is apparent when percent counts per minute in each 
peak are calculated), identifying this material as an oligosac- 
charide with a  single phosphodiester. The combined treat- 
ments of mild acid followed by alkaline phosphatase diges- 
tion  caused  63 %  of the  radioactivity to  run through  the 
column,  characteristic of neutral oligosaccharides (Fig.  5 
C). This confirms that the material eluting at 140 mM, and 
at least part of that at 70 mM, contains oligosaccharides with 
phosphomonoesters.  Insufficient material  was  available to 
confirm the  nature of the  radioactivity eluting at 70 mM 
NaCI  after  these  combined  treatments.  It  most  likely 
represents incomplete digestion by the alkaline phosphatase 
as  other  samples,  subsequently  shown  to  contain  phos- 
phomonoesters, were also incompletely digested with the en- 
zyme preparation used for these experiments. A similar anal- 
ysis of  the endogenous glycoproteins of  Xenopus oocytes also 
demonstrated  phosphorylated  oligosaccharides  by  QAE- 
Sephadex chromatography; Man-6-P residues were directly 
demonstrated by total acid hydrolysis of endo H-released 
oligosaccharides followed by paper chromatography (9; data 
not shown). 
Sucrose-Gradient Fractionation 
A previous study (37) on characterization of lysosomes from 
stage V-VI Xenopus  oocytes by sucrose-gradient fraction- 
ation demonstrated two distinct populations of lysosomes: 
(a) a subpopulation of yolk platelets, termed light yolk plate- 
lets, which contain the majority of the lysosomal enzyme ac- 
tivity, and (b) a population of"light lysosomes" which appear 
as a broad band sedimenting between 1.12 and 1.18 g/ml su- 
crose. The light yolk platelets are an apparent precursor to 
heavy yolk platelets, which are the final destination of the 
majority of yolk proteins (37).  However, little hydrolase ac- 
tivity is associated with the heavy yolk platelets. Stage V-VI 
oocytes, injected with cathepsin D RNA, were labeled with 
Faust et al.  Human Cathepsin  D in Xenopus Oocytes  1941 b3gure 6. Sucrose-gradient fractionation of oocytes injected with cathepsin D RNA. Injected oocytes were labeled with [35S]methionine 
and incubated for a total of (A) 5, (B) 30, or (C, D) 70 h. Oocytes in B and C were removed from the labeling medium after 24 and 64 h, 
respectively, and incubated with 0.5 mg/ml VG for 6 h. Oocytes were then homogenized and applied to linear sucrose gradients for analysis 
of the NAG and cathepsin D distribution. Insets: The cathepsin D distribution was determined by immunoprecipitation of odd-numbered 
gradient fractions except in the light yolk platelet (LP) and heavy yolk platelet (liP) region where every fraction was analyzed. TH, total 
homogenate applied to sucrose gradient immunoprecipitated with (a) anticathepsin D serum or (b) nonimnmne serum. The positions of 
precursor (P), intermediate (1), and mature (M) forms of cathepsin D are indicated. Characteristic regions of the gradient are indicated 
for the gel lanes: LL, light lysosome region, 1.12-1.18  g/ml; LP, light yolk platelets, 1.21 g/ml; HP, heavy yolk platelets, 1.23 g/ml sucrose 
(note that the gel lanes do not necessarily line up with the densitities indicated in the graph). Graphs: NAG activity (I) was assayed using 
p-nitrophenyl-N-acetylglucosamine as a substrate. The cathepsin D distribution was quantified by excising appropriate regions of  the dried 
get (inset) and measuring the radioactivity by liquid scintillation counting. Precursor (o) and processed (zx; intermediates + mature) forms 
were excised separately. 
[35S]methionine  and then fractionated on identical sucrose 
gradients in order to follow the compartmental distribution 
of cathepsin  D  during  its  biosynthesis  and  to  determine 
whether it is targeted to the light yolk platelets. The distribu- 
tion of the endogenous NAG activity was  determined for 
comparison.  In agreement with previous findings,  a  large 
peak of NAG activity is associated with the light yolk platelet 
compartment, which bands at 1.21 g/ml sucrose, and a sec- 
ond peak of NAG activity is found in the broad band corre- 
sponding to the light lysosome region (Fig. 6). The heavy 
yolk platelets, which band at 1.23 g/ml, have little associated 
NAG activity. The large amount of nonsedimentable NAG 
activity observed in these gradients most likely represents 
release of  NAG during homogenization, predominantly from 
the fragile light yolk platelets (37). 
The distribution of cathepsin D across the gradients was 
determined by immunoprecipitation followed by SDS-PAGE 
and was quantified by solubilization and scintillation count- 
ing of appropriate regions of the dried gels (Fig. 6). After 
5 h of incubation, a time at which some phosphorylation but 
no proteolytic processing of cathepsin D has occurred (Fig. 
2),  the precursor Mr 47,000-D  form of cathepsin D  sedi- 
mented as a broad band between 1.t2 and  1.18 g/ml with a 
distinct peak at 1.154 g/ml (Fig. 6 A). Precursor was not de- 
tected in the light yolk platelet region at this time. After 30 h 
of incubation (Fig. 6 B), most of the precursor remains at 
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Xenopus Oocytes 
Man-6-P- 
Oocyte  Oocytes  Addition  specific 
isolation  per well  Time  to assay  '251  uptake 
Collagenase 
treated 
Manually 
dissected 
n  h  cpm 
15  6  --  676 
613 
Man-6-P  63 
15  24  -  3,236  3,006 
Man-6-P  230 
20  6  -  1,139  910 
Man-6-P  229 
20  24  -  3,828  3,193 
Man-6-P  635 
30  24  -  7,524 
Man-6-P  1,445  6,079 
GIc-6-P  15,370 
Oocytes  were  isolated by manual dissection  or collagenase  dissociation  and 
then  incubated  with  ~2~l-lysosomal enzymes  in  the  presence  or absence  of 
Man-6-P or GIc-6-P. After the indicated time,  the oocytes were washed and 
counted  directly  for '25I in a  gamma-counter.  All determinations  were  per- 
formed on duplicate wells of oocytes. 
1.154 g/ml. In contrast, processed forms of cathepsin D (in- 
termediates and mature form) appear in two distinct regions: 
one peak at 1.135 g/ml, in the light lysosome region of the 
gradient and somewhat separate from the precursor peak, 
and a  second peak at  1.21 g/ml, in the light yolk platelet 
band. Small amounts of precursor were also detected in the 
1.21 g/ml region of the gradient. By 70 h, even more of the 
cathepsin D sedimented with the light yolk platelets (Fig. 6, 
C and D) and it is in a predominantly processed form. The 
distribution of cathepsin D at this time is identical to that of 
NAG.  As observed for NAG, there is little cathepsin D as- 
sociated with the heavy yolk platelets at 1.23 g/ml. In addi- 
tion, to determine whether endocytosis of the yolk protein 
VG was required for cathepsin D to reach the light yolk plate- 
let compartment, some oocytes were incubated with VG for 
6 h before homogenization. This incubation had no discerna- 
ble effect on the distribution of  cathepsin D in these gradients 
at the 30- (30 h without VG not shown) and 70-h time points 
(Fig. 6, C and D, with and without VG, respectively). The 
large amount of cathepsin D which was nonsedimentable in 
these gradients was probably released largely from damaged 
yolk platelets since there was a greater release of processed 
forms  compared  to  the  precursor.  These  gradients  have 
defined three distinct compartments traversed by cathepsin 
D  during its biosynthesis: a  1.154-g/ml band which is en- 
riched for precursor, a 1.135-g/ml band which is enriched for 
processed forms, and the 1.21-g/ml light yolk platelet band. 
L  ysosomai Enzyme Uptake 
In some simple eukaryotic organisms, such as the soil ameba 
Acanthamoeba castellani and the slime mold Dicryostelium 
discoideum, the phosphotransferase enzyme is present (24) 
but it has not yet been determined whether these cells utilize 
the Man-6-P marker for intracellular targeting of lysosomal 
hydrolases. It was of interest, then, to determine whether oo- 
cytes have a Man-6-P receptor which could function to target 
phosphorylated lysosomal enzymes to lysosomes. To inves- 
tigate this, phosphorylated lysosomal enzymes were isolated 
from secretions of a murine lymphoma cell line and iodi- 
nated. Oocytes were then incubated with the 12SI-lysosomal 
enzymes in the presence and absence of Man-6-P. As shown 
in Table III, oocytes isolated by manual dissection or col- 
lagenase dissociation (a procedure that releases the adherent 
follicle cells) were capable of taking up ~25I-lysosomal  en- 
zymes from the medium and this uptake was inhibited by 
Man-6-P.  GIc-6-P did not inhibit uptake (the increased up- 
take in the presence of GIc-6-P is not understood but is con- 
sistently observed). The linear increase in cell-associated ra- 
dioactivity with time suggests that the lysosomal enzymes 
are being internalized and accumulating within the oocyte. 
Manually dissected oocytes endocytosed similar levels of ra- 
dioactivity as collagenase-treated oocytes, indicating that the 
uptake was due to the oocytes and not to follicle cell contami- 
nation.  Although oocytes can  take up  serum proteins  by 
fluid-phase endocytosis (40), the demonstrated inhibition by 
Man-6-P indicates that the lysosomal enzyme uptake is a 
specific receptor-mediated process. In addition, preliminary 
studies  of  [35S]methionine-labeled  oocytes  have  demon- 
strated oocyte proteins of Mr ,,o215,000 and 43,000 D which 
are  capable  of  specifically  binding  to  phosphomannan- 
Sepharose  in  a  cation-independent and  cation-dependent 
manner, respectively (N.  Dahms and S.  Kornfeld, unpub- 
lished  observations).  Thus  oocytes  have  two  Man-6-P- 
binding proteins which have properties similar to the two 
Man-6-P receptors characterized in mammalian cells (20, 
31). 
This  specific uptake of lysosomal enzymes by oocytes 
raised the possibility that the observed targeting of cathepsin 
D to lysosomes (Fig. 6) may occur by a secretion-recapture 
mechanism rather than a direct intracellular pathway. To in- 
vestigate this possibility, oocytes were injected with cathep- 
sin D message and then labeled with [35S]methionine in the 
presence or absence of Man-6-P or GIc-6-P. The addition of 
Man-6-P or GIc-6-P to the labeling medium had no effect on 
the distribution between cells and medium and the intracellu- 
lar processing of cathepsin D (data not shown). This finding 
is consistent with studies in mammalian cells which indicate 
that secretion-recapture plays a minor role in the targeting 
of newly synthesized lysosomal enzymes (3,  17). 
Discussion 
The data presented in this paper demonstrate that human 
cathepsin D expressed in Xenopus laevis oocytes acquires 
phosphomannosyl residues and is targeted to lysosomes. In 
agreement with biosynthetic studies on cathepsin D in mam- 
malian cells (6,  12,  15,  16, 30), most of the cathepsin D in 
oocytes  remains  intracellular  and  undergoes  proteolytic 
cleavage upon delivery to lysosomal organelles. The cathep- 
sin D that is secreted (5-25 %) is the higher molecular mass 
precursor form, presumably procathepsin D (6). 93-97 % of 
the cathepsin D molecules synthesized by the oocyte were 
phosphorylated,  demonstrating  that  the  oocyte phospho- 
transferase is capable of efficiently recognizing this mam- 
malian lysosomal enzyme. We have also demonstrated that 
the nonrelated glycoproteins ovalbumin and a-lactalbumin 
do not acquire phosphomannosyl residues in the oocyte (7), 
thus indicating the specificity of the phosphorylation event. 
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from that previously observed in mammalian cells. First, the 
mature  form in  oocytes is  a  protein  of Mr 39,000 D  (M~ 
45,000 D on reducing gels) rather than the two-chain form 
with Mr values of 31,000 and 14,000 D (17). In mammalian 
cells, inhibitors of lysosomal cysteine proteinases block con- 
version of the single chain enzyme to the mature two-chain 
form (11). The lysosomal organdies in Xenopus oocytes have 
an unusual enzymatic composition with little proteolytic ac- 
tivity (37). Indeed, cathepsin B, a cysteine protease, was not 
detected in oocytes (37). The persistence of the single-chain 
cathepsin D is, therefore, consistent with the unusual content 
of the oocyte lysosome. Secondly, the proteolytic cleavage of 
the Mr 47,000-D precursor to the Mr 39,000-D mature form 
occurred in multiple steps. The size of the total molecular 
mass decreased and the demonstrated correlation of cleavage 
with  phosphorylation  (Fig.  2)  and  delivery  to  lysosomal 
organdies (Fig. 6) is consistent with the cleavage represent- 
ing removal of the cathepsin D propiece. A study on the acti- 
vation mechanism of pepsinogen (22), a related aspartyt pro- 
tease,  demonstrated  that  removal  of the  propeptide  may 
occur by a direct conversion, with release of the intact pro- 
peptide, or by a sequential pathway in which one or more in- 
termediates can be identified. The propeptide of cathepsin D 
is also postulated to act as an activation  segment (6,  18). 
Hasilik et al. (18) reported that in vitro activation of cathep- 
sin D  shifted the Mr from 53,000 to 51,500 D  and not to 
47,000 D as seen in intact cells. This Mr 51,500-D form may 
then represent an intermediate in the removal of  the propiece, 
analogous to that seen in oocytes. The reason why these in- 
termediates in cathepsin D biosynthesis are observed in oo- 
cytes but not in mammalian cells may relate to the slower rate 
at which cathepsin D is translocated to tysosomes as well as 
to  differences  in  the  enzymic  content  of the  lysosomal 
organdies. 
The sucrose-gradient analysis demonstrates that cathepsin 
D is retained in intracellular membranous vesicles and is tar- 
geted to lysosomal organdies,  the light lysosomes and the 
light yolk platelets. In the light lysosome region of the gra- 
dient,  from  1.12 to  1.18 g/ml  sucrose, precursor and pro- 
cessed forms band at slightly different densities suggesting 
that  these forms of cathepsin  D  are in different compart- 
ments.  The  precursor,  which  designates  an  early biosyn- 
thetic  form,  bands  at  1.154 g/ml  sucrose and most likely 
represents  cathepsin  D  in  endoplasmic  reticulum  and/or 
Golgi membranes. It has been demonstrated that the proteo- 
lytic processing of cathepsin D is initiated in prdysosomal 
compartments of mammalian cells (12). By analogy, in oo- 
cytes the processed cathepsin D, at 1.135 g/ml, may reside 
in primary lysosomes formed by the Golgi apparatus and/or 
in  multivesicular  pretysosomat  bodies.  The  compartment 
that the cathepsin D next enters is at 1.21 g/ml sucrose, which 
corresponds to the peak of NAG activity and the position of 
the light yolk platelets. The cathepsin D in this compartment 
is predominantly  the processed form,  as also observed in 
mammalian  lysosomes (12,  17). 
Pulse-chase  studies with  125I-VG have demonstrated  that 
the ligand is first found in the light yolk platelet region of the 
gradient before its appearance in the heavy platelets, which 
are the final destination of yolk proteins (37). In contrast to 
the light yolk platelets, the heavy platelets have little associ- 
ated hydrolase activity. In agreement with this finding, little 
cathepsin D was associated with the heavy platelets at 1.23 
g/ml. Inasmuch as immunoprecipitable protein and not en- 
zymatic activity was measured for cathepsin D in this study, 
this finding suggests that the absence of hydrolytic activity 
in  the  heavy platdets  is  not due  to enzyme  inactivation. 
Rather,  absence of the enzymes in the heavy yolk platelet 
compartment may occur either by their degradation in or re- 
cycling out of this compartment. 
In many cell types, multivesicular bodies (MVBs) appear 
to be the point at which lysosomal enzymes are introduced 
into the endocytic pathway (21). MVBs play a central role in 
the endocytic pathway of the yolk protein precursor VG in 
Xenopus oocytes (38). VG is destined for long-term storage 
in yolk platelets as protein crystals, and the MVB is the site 
in which the condensation and crystallization of the yolk pro- 
teins is initiated (38). The MVB also appears to be the site 
in which VG processing to mature yolk proteins begins, since 
MVBs as light as t.10-1.12  g/ml sucrose appear to contain 
cleaved VG, suggesting that protease activity is present in 
these organdies (39). In the studies reported here, processed 
forms of cathepsin D were found at densities from 1.12 to 1.18 
g/ml, and their presence there was unaltered by VG endocy- 
tosis. Because incoming VG rapidly increases the density of 
the endocytic organdies containing this ligand, this observa- 
tion indicates that the lighter density compartments contain- 
ing processed cathepsin D are inaccessible to newly internal- 
ized VG, and thus are distinct from endosomal organdies of 
the VG endocytic pathway (39). A class of MVBs that do not 
fuse with endosomes containing newly internalized VG has 
been described (39), although direct morphological localiza- 
tion will be required to confirm that cathepsin D or other 
hydrolases are found in these organelles. 
Introduction of tysosomal enzymes into the VG endocytic 
pathway at the level of MVBs or other endosomes would ini- 
tially  place the  hydrolases  in  a  relatively  low-density or- 
ganelle. On the sucrose gradients used here, ligand-contain- 
ing organelles from 1.I0 to 1.20 g/ml consist predominantly 
of MVBs containing yolk proteins in varying stages of con- 
densation and crystallization (38, 39). Appearance of cathep- 
sin D in light yolk platelets at 1.21 g/ml would require either: 
(a) transformation of MVBs into light yolk platelets by the 
accumulation  and  crystallization  of yolk proteins  within 
them,  or b) fusion of MVBs or primary  lysosomes with 
preexisting light yolk platdets. In this study, concurrent VG 
endocytosis was not required for appearance of cathepsin D 
in platelets, indicating that the first alternative is incorrect. 
Thus it appears that either fusion of primary lysosomes with 
MVBs and their eventual delivery to platelets occurs even 
when MVBs contain no VG, or that a direct pathway for ly- 
sosomal enzyme delivery to light platelets exists which does 
not involve endosomat MVBs (i.e., direct fusion of primary 
lysosomes with light yolk platelets). 
Xenopus oocytes have been utilized for the expression of 
a variety of foreign proteins,  and they are capable of per- 
forming  many  posttranslational  modifications  as  well  as 
directing the correct cellular location of the expressed pro- 
teins (2). The data presented here establish that Xenopus oo- 
cytes have the phosphotransferase enzyme required for gen- 
eration of the Man-6-P marker. The ability of the oocytes to 
endocytose phosphorylated  lysosomal enzymes also  indi- 
cates the presence of a Man-6-P receptor that could serve to 
target the phosphorylated lysosomal enzymes to lysosomes. 
The Journal of Cell Biology, Volume I05,  1987  1944 Thus,  the  entire  Man-6-P dependent  targeting pathway  is 
present in the oocyte. Given the efficiency of cDNA expres- 
sion utilizing transcription-linked  translation,  Xenopus oo- 
cytes should prove to be a versatile system for examining the 
protein determinants on lysosomal enzymes that are neces- 
sary for targeting to lysosomes. 
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